Cargando…

Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?

Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women. In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT). In women, breast cancer (BC) is the leading cause of...

Descripción completa

Detalles Bibliográficos
Autores principales: Peix, Amalia, Perez, Aylen, Barreda, Ana Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291578/
https://www.ncbi.nlm.nih.gov/pubmed/37377450
http://dx.doi.org/10.15420/ecr.2022.36
_version_ 1785062719516311552
author Peix, Amalia
Perez, Aylen
Barreda, Ana Maria
author_facet Peix, Amalia
Perez, Aylen
Barreda, Ana Maria
author_sort Peix, Amalia
collection PubMed
description Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women. In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT). In women, breast cancer (BC) is the leading cause of cancer death and thoracic RT is a main component of the treatment in many cases. Nevertheless, despite new techniques that limit the area receiving RT, cardiac damage is still an important concern in BC patients. In this review, the following aspects will be addressed: pathophysiology of postradiotherapy heart damage in women with BC; mechanisms, diagnosis and prevention/management of heart damage; and future areas of potential research for radiotherapy injury in women.
format Online
Article
Text
id pubmed-10291578
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-102915782023-06-27 Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts? Peix, Amalia Perez, Aylen Barreda, Ana Maria Eur Cardiol Cardio-Oncology Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women. In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT). In women, breast cancer (BC) is the leading cause of cancer death and thoracic RT is a main component of the treatment in many cases. Nevertheless, despite new techniques that limit the area receiving RT, cardiac damage is still an important concern in BC patients. In this review, the following aspects will be addressed: pathophysiology of postradiotherapy heart damage in women with BC; mechanisms, diagnosis and prevention/management of heart damage; and future areas of potential research for radiotherapy injury in women. Radcliffe Cardiology 2023-03-29 /pmc/articles/PMC10291578/ /pubmed/37377450 http://dx.doi.org/10.15420/ecr.2022.36 Text en Copyright © 2023, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Cardio-Oncology
Peix, Amalia
Perez, Aylen
Barreda, Ana Maria
Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
title Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
title_full Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
title_fullStr Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
title_full_unstemmed Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
title_short Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
title_sort cancer and postradiotherapy cardiotoxicity: how to face damage in women’s hearts?
topic Cardio-Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291578/
https://www.ncbi.nlm.nih.gov/pubmed/37377450
http://dx.doi.org/10.15420/ecr.2022.36
work_keys_str_mv AT peixamalia cancerandpostradiotherapycardiotoxicityhowtofacedamageinwomenshearts
AT perezaylen cancerandpostradiotherapycardiotoxicityhowtofacedamageinwomenshearts
AT barredaanamaria cancerandpostradiotherapycardiotoxicityhowtofacedamageinwomenshearts